P. Pitisuttithum

J. Perfect, P. Pitisuttithum, J. Graybill, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recruiting Volunteers for a Multisite Phase I/II HIV Preventive Vaccine Trial in Thailand

P. Pitisuttithum, S. Nitayaphan, J. Chiu, 2002, Journal of acquired immune deficiency syndromes.

A review of epidemic preparedness for influenza through local vaccine production: national security for Thailand

P. Pitisuttithum, P. Wirachwong, 2019, Human vaccines & immunotherapeutics.

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

S. Lamola, M. Lal, P. Pitisuttithum, 2022, eClinicalMedicine.

Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage

S. Kochhar, J. Bauwens, P. Pitisuttithum, 2018, Journal of clinical pharmacology.

Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer

P. Pitisuttithum, S. Kamolratanakul, Supitcha Kamolratanakul, 2021, Vaccines.

Clinical features, etiology and short term outcomes of interstitial pneumonitis in HIV/AIDS patients.

P. Pitisuttithum, J. Kaewkungwal, B. Karmacharya, 2005, The Southeast Asian journal of tropical medicine and public health.

Clinical features, aetiology and short-term outcome of interstitial pneumonitis in HIV/AIDS patients at Bamrasnaradura Hospital, Nonthaburi, Thailand

W. Wernsdorfer, A. Das, P. Pitisuttithum, 2005, Wiener klinische Wochenschrift.

V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144

Allan C. deCamp, Jerome H. Kim, D. Montefiori, 2017, PloS one.

Effects of cigarette smoking on quinine pharmacokinetics in malaria

P. Pitisuttithum, S. Pukrittayakamee, S. Wanwimolruk, 2002, European Journal of Clinical Pharmacology.

Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: two- and three-day regimens.

P. Pitisuttithum, S. Looareesuwan, P. Wilairatana, 1996, The American journal of tropical medicine and hygiene.

Mycobacterium tuberculosis infection among HIV/AIDS patients in Thailand: clinical manifestations and outcomes.

P. Pitisuttithum, U. Silachamroon, V. Bussaratid, 2002, The Southeast Asian journal of tropical medicine and public health.

HIV Incidence and Risk Behaviours of People Who Inject Drugs in Bangkok, 1995–2012

J. Tappero, P. Pitisuttithum, J. Kaewkungwal, 2019, EClinicalMedicine.

Adherence and Health Problems in Thai Travellers Living with HIV

P. Pitisuttithum, W. Piyaphanee, S. Lawpoolsri, 2022, Tropical medicine and infectious disease.

Establishment of a Shigella sonnei human challenge model in Thailand.

P. Pitisuttithum, C. Mason, L. Bodhidatta, 2012, Vaccine.

Evaluation of attitude, risk behavior and expectations among Thai participants in Phase I/II HIV/AIDS vaccine trials.

P. Pitisuttithum, W. Maek-a-nantawat, V. Bussaratid, 2003, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Knowledge, attitudes, and acceptability of a human papillomavirus vaccine among healthcare providers.

P. Pitisuttithum, J. Kaewkungwal, W. Fungladda, 2009, The Southeast Asian journal of tropical medicine and public health.

Social restriction versus herd immunity policies in the early phase of the SARS-CoV-2 pandemic: A mathematical modelling study.

P. Pitisuttithum, K. Pongpirul, P. Wilairatana, 2021, Asian Pacific journal of allergy and immunology.

A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis.

P. Newton, P. Pitisuttithum, N. White, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients.

P. Pitisuttithum, S. Tansuphaswadikul, W. Maek-a-nantawat, 2006, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV

P. Pitisuttithum, A. Luxembourg, C. Velicer, 2015, Expert review of vaccines.

Microsporidium: modified technique for light microscopic diagnosis.

P. Pitisuttithum, B. Punpoowong, D. Chindanond, 1995, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations

Jerome H. Kim, M. Robb, S. Rerks-Ngarm, 2018, PloS one.

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

Jerome H. Kim, H. Liao, B. Haynes, 2013, Proceedings of the National Academy of Sciences.

Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents.

J. Kublin, D. Mehrotra, J. Shiver, 2005, The Journal of infectious diseases.

Costs of Chronic Hepatitis B patients in a developing country

P. Pitisuttithum, Chuenrutai Yeekian, 2014 .

Long term outcomes of nevirapine containing antiretroviral therapy at a center in Thailand.

P. Pitisuttithum, B. Phonrat, C. Bowonwatanuwong, 2012, The Southeast Asian journal of tropical medicine and public health.

Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan).

Jerome H. Kim, D. Cooper, S. Kent, 2011, The Southeast Asian journal of tropical medicine and public health.

Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia

D. Cooper, S. Kent, S. Osmanov, 2010, Current opinion in HIV and AIDS.

AIDS Vaccine for Asia Network (AVAN): Expanding the Regional Role in Developing HIV Vaccines

D. Cooper, S. Kent, S. Osmanov, 2010, PLoS medicine.

Expanding research capacity and accelerating AIDS vaccine development in Asia.

S. Osmanov, S. Rerks-Ngarm, P. Pitisuttithum, 2008, The Southeast Asian journal of tropical medicine and public health.

Health in Action Aids Vaccine for Asia Network (avan): Expanding the Regional Role in Developing Hiv Vaccines the Need for Avan: the Hiv Epidemic in the Asian Region

D. Cooper, S. Kent, S. Osmanov, 2022 .

Effectiveness of fixed-dose combination stavudine, lamivudine and nevirapine (GPO-VIR) for treatment of naïve HIV patients in Thailand: a 3-year follow-up.

P. Pitisuttithum, S. Tansuphaswadikul, B. Karmacharya, 2011, The Southeast Asian journal of tropical medicine and public health.

Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1

D. Douek, P. Gilbert, S. Rerks-Ngarm, 2021, eLife.

Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as the primary mechanism of vaccine-induced protection against HIV-1

D. Douek, P. Gilbert, S. Rerks-Ngarm, 2021, bioRxiv.

Gnathostoma larva migrans among guests of a New Year party.

P. Pitisuttithum, V. Desakorn, S. Migasena, 1991, The Southeast Asian journal of tropical medicine and public health.

Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.

J. Tappero, P. Pitisuttithum, F. van Griensven, 2009, Addiction.

Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand

J. Tappero, P. Pitisuttithum, F. van Griensven, 2004, AIDS.

COVID-19 vaccine strategies must focus on severe disease and global equity

S. Madhi, Rakesh Aggarwal, S. Kochhar, 2021, The Lancet.

Socio-economic status and prevalence of intestinal parasitic infection in Thai adults residing in and around Bangkok metropolis.

P. Pitisuttithum, S. Migasena, A. Juntra, 1990, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis.

P. Pitisuttithum, W. Supanaranond, D. Chindanond, 1995, The Southeast Asian journal of tropical medicine and public health.

Monotherapy with sodium artesunate for uncomplicated falciparum malaria in Thailand: a comparison of 5- and 7-day regimens.

P. Pitisuttithum, S. Looareesuwan, P. Wilairatana, 1997, Acta tropica.

Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria.

D. Kyle, P. Pitisuttithum, S. Looareesuwan, 1997, The American journal of tropical medicine and hygiene.

Incidence of foodborne illness in Southeast Asia

M. Miliotis, J. W. Bier, P. Pitisuttithum, 2003 .

Clinical Factors for Severity of Plasmodium falciparum Malaria in Hospitalized Adults in Thailand

P. Pitisuttithum, W. Chierakul, V. Desakorn, 2013, PloS one.

An HIV Vaccine for South-East Asia—Opportunities and Challenges

Jerome H. Kim, S. Rerks-Ngarm, P. Pitisuttithum, 2013, Vaccines.

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Galit Alter, David C Montefiori, Nigel Garrett, 2018, The Lancet.

Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial

Allan C. deCamp, Jerome H. Kim, D. Montefiori, 2017, The Journal of infectious diseases.

The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection

Punnee Pitisuttithum, P. Pitisuttithum, A. Bouckenooghe, 2016, Expert review of vaccines.

RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection

Jerome H. Kim, J. Mullins, Hongjun Bai, 2021, Virus evolution.

Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial

Raphael Gottardo, Tomer Hertz, Sergei L. Kosakovsky Pond, 2015, PLoS Comput. Biol..

Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.

S. Hammer, J. Kublin, S. Self, 2010, AIDS research and human retroviruses.

Knowledge, attitude, and practices toward COVID-19 among the international travelers in Thailand

P. Pitisuttithum, W. Piyaphanee, V. Luvira, 2021, Tropical Diseases, Travel Medicine and Vaccines.

A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future.

Diane J Post, G. Kang, B. Cowling, 2021, Vaccine.

Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

Terri Wrin, Josephine Birungi, Dennis R. Burton, 2009, Journal of Virology.

Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization Breadth

Hongjun Bai, E. Sanders-Buell, M. Robb, 2021, Journal of virology.

Machine Learning Methods Enable Predictive Modeling of Antibody Feature:Function Relationships in RV144 Vaccinees

Chris Bailey-Kellogg, Jaranit Kaewkungwal, Todd J. Suscovich, 2015, PLoS Comput. Biol..

Infectious Virion Capture by HIV-1 gp120-Specific IgG from RV144 Vaccinees

Jerome H. Kim, H. Liao, J. Kappes, 2013, Journal of Virology.

Virion Capture by HIV-1 gp 120-Specific IgG from RV 144 Vaccinees

Jerome H. Kim, H. Liao, J. Kappes, 2013 .

Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection

Gary J. Nabel, Youyi Fong, Peter B. Gilbert, 2014, PloS one.

The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.

Jerome H. Kim, B. Korber, B. Haynes, 2012, AIDS research and human retroviruses.

Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family

Jerome H. Kim, X. Chen, H. Liao, 2012, Journal of Virology.

HIV/AIDS in Thailand

P. Pitisuttithum, N. Bhamarapravati, C. Kunanusont, 2004 .

Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.

D. Birx, P. Pitisuttithum, S. Nitayaphan, 2005, Vaccine.

Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying env from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism

Jerome H. Kim, D. Montefiori, M. Robb, 2018, Journal of Virology.

HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial

Jerome H. Kim, C. Andrews, M. Robb, 2014, Immunogenetics.

Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand

Jerome H. Kim, D. Stablein, M. Robb, 2011, PloS one.

Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses.

Jerome H. Kim, H. Liao, B. Haynes, 2014, The Journal of infectious diseases.

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E.

Jerome H. Kim, P. Pitisuttithum, S. Nitayaphan, 2012, Vaccine.

Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques.

Jerome H. Kim, H. Liao, Laura L. Sutherland, 2016, JCI insight.

HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition

Allan C. deCamp, Jerome H. Kim, S. Zolla-Pazner, 2015, Science Translational Medicine.

Comparison of clinical outcomes between HIV-infected patients with and without HCV co-infection in a resource-limited setting.

P. Pitisuttithum, J. Kaewkungwal, S. Sungkanuparph, 2012, The Southeast Asian journal of tropical medicine and public health.

Etiology, Clinical Course, and Outcomes of Pneumonia in the Elderly: A Retrospective and Prospective Cohort Study in Thailand

P. Pitisuttithum, J. Kaewkungwal, U. Silachamroon, 2021, The American journal of tropical medicine and hygiene.

The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope

Jaranit Kaewkungwal, Nelson L Michael, Supachai Rerks-Ngarm, 2012, The Journal of Immunology.

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.

Jaranit Kaewkungwal, Joseph Chiu, Nelson L Michael, 2012, The Lancet. Infectious diseases.

Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines

Jerome H. Kim, C. Bailey-Kellogg, C. Andrews, 2014, Science Translational Medicine.

Correlation of Susceptibility of Cryptococcus neoformans to Amphotericin B with Clinical Outcome

A. Simpson, P. Pitisuttithum, N. Day, 2011, Antimicrobial Agents and Chemotherapy.

Impact of diabetes mellitus on clinical parameters and treatment outcomes of newly diagnosed pulmonary tuberculosis patients in Thailand

P. Pitisuttithum, C. Chuchottaworn, V. Desakorn, 2013, International journal of clinical practice.

A 9-valent HPV vaccine against infection and intraepithelial Neoplasia in women

J. Cuzick, A. Giuliano, S. Kjaer, 2015 .

Immunogenicity and Safety of a 9-Valent HPV Vaccine

X. Castellsagué, P. van Damme, P. Pitisuttithum, 2015, Pediatrics.

Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

Hasan Ahmed, Hongmei Gao, Jaranit Kaewkungwal, 2012, The Journal of infectious diseases.

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

Punnee Pitisuttithum, P. Gilbert, J. Tappero, 2006, The Journal of infectious diseases.

A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination

S. Kent, S. Rerks-Ngarm, P. Pitisuttithum, 2021, Cell reports. Medicine.

Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine – A combined analysis of five phase III clinical trials

J. Cuzick, A. Giuliano, S. Kjaer, 2017, Papillomavirus research.

Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparum.

K. Silamut, P. Pitisuttithum, N. Day, 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Aggregate complexes of HIV-1 induced by multimeric antibodies

Jerome H. Kim, B. Haynes, D. Montefiori, 2014, Retrovirology.

CD8 and CD4 Epitope Predictions in RV144: No Strong Evidence of a T-Cell Driven Sieve Effect in HIV-1 Breakthrough Sequences from Trial Participants

Lindsay N. Carpp, Jerome H. Kim, H. Liao, 2014, PloS one.

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens

Jerome H. Kim, M. Robb, S. Rerks-Ngarm, 2017, AIDS Research and Human Retroviruses.

Dengue and Other Common Causes of Acute Febrile Illness in Asia: An Active Surveillance Study in Children

Stephen J. Thomas, P. Pitisuttithum, K. Rusmil, 2013, PLoS neglected tropical diseases.

Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, Thailand

M. Robb, P. Pitisuttithum, S. Nitayaphan, 2021, EClinicalMedicine.

Beyond RV144 Efficacy Results: An Update☆

Jerome H. Kim, P. Pitisuttithum, J. Excler, 2013 .

Vaccine development lessons between HIV and COVID-19

P. Pitisuttithum, S. Vasan, 2021, The Lancet Infectious Diseases.

A human volunteer challenge model using frozen bacteria of the new epidemic serotype, V. cholerae O139 in Thai volunteers.

M. Cohen, P. Pitisuttithum, P. Singhasivanon, 2001, Vaccine.

6-month evaluation of JinHuang Chinese herbal medicine study in asymptomatic HIV infected Thais.

P. Pitisuttithum, W. Maek-a-nantawat, V. Bussaratid, 2003, The Southeast Asian journal of tropical medicine and public health.

Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003.

J. Tappero, P. Pitisuttithum, F. van Griensven, 2010, The International journal on drug policy.

Issues in women's participation in a phase III community HIV vaccine trial in Thailand.

Jerome H. Kim, S. Rerks-Ngarm, P. Pitisuttithum, 2013, AIDS research and human retroviruses.

Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor

Jerome H. Kim, S. Zolla-Pazner, S. Rerks-Ngarm, 2015, PloS one.

Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults

P. Pitisuttithum, J. Kaewkungwal, C. Mason, 2016, Clinical and Vaccine Immunology.

Antimicrobial Stewardship in Tropical Infectious Diseases: Focusing on Dengue and Malaria

P. Pitisuttithum, V. Luvira, S. Lawpoolsri, 2022, Tropical medicine and infectious disease.

Treatment of acute, uncomplicated, falciparum malaria with oral dihydroartemisinin.

P. Pitisuttithum, S. Looareesuwan, K. Kraisintu, 1996, Annals of tropical medicine and parasitology.

Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial

Jerome H. Kim, T. Kepler, H. Liao, 2017, PLoS pathogens.

Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants

P. Hansasuta, P. Pitisuttithum, A. Jongkaewwattana, 2023, International Journal of Infectious Diseases.

HIV‐specific antibody‐dependent phagocytosis matures during HIV infection

Jerome H. Kim, R. Center, S. Kent, 2014, Immunology and cell biology.

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

James Y. Dai, Jerome H. Kim, H. Liao, 2014, The Journal of clinical investigation.

IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees

G. Alter, S. Rerks-Ngarm, P. Pitisuttithum, 2020, JCI insight.

Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune response.

Jerome H. Kim, M. Robb, G. Alter, 2020, JCI insight.

HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees

Allan C. deCamp, B. Korber, P. Hraber, 2018, Journal of Virology.

HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis

Jerome H. Kim, H. Liao, B. Haynes, 2018, Journal of Virology.

Vaccine-Induced HIV-1 Envelope gp120 Constant Region 1-Specific Antibodies Expose a CD4-Inducible Epitope and Block the Interaction of HIV-1 gp140 with Galactosylceramide

Jerome H. Kim, H. Liao, B. Haynes, 2014, Journal of Virology.

COMPASS identifies T-cell subsets correlated with clinical outcomes

Greg Finak, Raphael Gottardo, Jaranit Kaewkungwal, 2015, Nature Biotechnology.

HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities

Jerome H. Kim, H. Liao, B. Haynes, 2014, Journal of Virology.

HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions.

Jerome H. Kim, P. Zhang, E. Go, 2020, JCI insight.

Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency

Jerome H. Kim, T. Kepler, B. Haynes, 2019, Journal of Virology.

Immune responses to intradermal and intramuscular inactivated influenza vaccine among older age group.

P. Pitisuttithum, P. Puthavathana, K. Boonnak, 2017, Vaccine.

A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infection

Jerome H. Kim, Yufei Wang, T. Whittall, 2017, Scientific Reports.

Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand.

P. Pitisuttithum, W. Chierakul, W. Manosuthi, 2013, The Southeast Asian journal of tropical medicine and public health.

An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination

J. Wrammert, D. Sather, P. Pitisuttithum, 2023, Science Translational Medicine.

Resource Use and Costs of Dengue: Analysis of Data from Phase III Efficacy Studies of a Tetravalent Dengue Vaccine

P. Pitisuttithum, L. Coudeville, G. Carrasquilla, 2017, The American journal of tropical medicine and hygiene.

Predisposing factors for nevirapine toxicity among AIDS patients with low baseline CD4 count.

P. Pitisuttithum, J. Kaewkungwal, S. Tansuphaswadikul, 2007, Asian Pacific journal of allergy and immunology.

Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion

Jerome H. Kim, Haiyan Chen, H. Liao, 2012, Journal of Virology.

Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease

M. Halloran, P. Gilbert, P. Pitisuttithum, 2018, PloS one.

Region of HIV-1 Envelope Preferentially Target Epitopes within the V2 Regimen Induces T Cell Responses That The Thai Phase III Trial (RV144) Vaccine

S. Rerks-Ngarm, P. Pitisuttithum, S. Nitayaphan, 2012 .

Selecting Participants Fairly for Controlled Human Infection Studies

P. Pitisuttithum, N. Jecker, Katherine W. Saylor, 2020, Bioethics.

Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

Jack Cuzick, Jorma Paavonen, Cosette M. Wheeler, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee☆

Jerome H. Kim, T. Kepler, H. Liao, 2015, EBioMedicine.

1174. Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Catch-up Vaccination Regimens of V114 in Healthy Infants, Children, and Adolescents (PNEU–PLAN)

M. Rämet, P. Pitisuttithum, R. Dagan, 2021, Open Forum Infectious Diseases.

The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients.

P. Pitisuttithum, S. Krudsood, P. Wilairatana, 2005, The Southeast Asian journal of tropical medicine and public health.

Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.

Punnee Pitisuttithum, Sorachai Nitayaphan, Victoria Polonis, 2004, The Journal of infectious diseases.

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens

Jerome H. Kim, C. Andrews, M. Robb, 2015, AIDS research and human retroviruses.

Trends in the injection of midazolam and other drugs and needle sharing among injection drug users enrolled in the AIDSVAX B/E HIV-1 vaccine trial in Bangkok, Thailand

J. Tappero, P. Pitisuttithum, F. Griensven, 2005 .

Considerations for unblinding individual study participants during vaccine trials.

C. Whitney, K. Edwards, P. Pitisuttithum, 2023, Vaccine.

Galactosylceramide the Interaction of HIV-1 gp 140 with Expose a CD 4-Inducible Epitope and Block Constant Region 1-Specific Antibodies Vaccine-Induced HIV-1 Envelope gp

Jerome H. Kim, H. Liao, B. Haynes, 2014 .

Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study.

P. Pitisuttithum, H. Reynales, I. Smolenov, 2021, The Lancet. Infectious diseases.

Safety and immune responses following administration of H1N1 live attenuated influenza vaccine in Thais.

P. Pitisuttithum, P. Puthavathana, S. Louisirirotchanakul, 2013, Vaccine.

Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1

H. Liao, B. Haynes, S. Rerks-Ngarm, 2017, Journal of Virology.

CLINICAL OUTCOMES OF CRYPTOCOCCAL MENINGITIS AMONG HIV-INFECTED PATIENTS IN THE ERA OF ANTIRETROVIRAL THERAPY.

P. Pitisuttithum, S. Sungkanuparph, A. Phuphuakrat, 2017, The Southeast Asian journal of tropical medicine and public health.

Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials

P. Pitisuttithum, N. H. Tran, A. Bouckenooghe, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial

P. Pitisuttithum, J. Excler, A. Jongkaewwattana, 2023, Vaccine.

Phase I/II Study of a Candidate Vaccine Designed Against the B and E Subtypes of HIV-1

H. Sheppard, P. Pitisuttithum, D. Francis, 2004, Journal of acquired immune deficiency syndromes.

Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.

Jerome H. Kim, D. Birx, P. Pitisuttithum, 2003, The Journal of infectious diseases.

Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine

Jerome H. Kim, R. Gottardo, R. Koup, 2019, Nature Communications.

Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis.

Jerome H. Kim, P. Pitisuttithum, J. Dhitavat, 2007, The Southeast Asian journal of tropical medicine and public health.

Accuracy of Clinical Diagnosis of Dengue Episodes in the RV144 HIV Vaccine Efficacy Trial in Thailand

Jerome H. Kim, D. Stablein, M. Robb, 2015, PloS one.

HIV-vaccine research and development in Thailand: evolution and challenges.

P. Pitisuttithum, K. Choopanya, Supachai Rerk-Ngnam, 2010, Vaccine.

HIV vaccine research in Thailand: lessons learned

P. Pitisuttithum, 2008, Expert review of vaccines.

Prophylactic HIV vaccine: vaccine regimens in clinical trials and potential challenges

P. Pitisuttithum, M. Marovich, 2020, Expert review of vaccines.

Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection

H. Liao, Laura L. Sutherland, B. Haynes, 2016, EBioMedicine.

Systematic comparison of HIV-1 Envelope-specific IgG responses induced by different vaccination regimens: Can we steer IgG recognition towards regions of viral vulnerability?

S. McCormack, M. Hoelscher, M. Robb, 2023, Frontiers in Immunology.

Social harms in injecting drug users participating in the first phase III HIV vaccine trial in Thailand.

J. Tappero, P. Pitisuttithum, D. Francis, 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1.

Jerome H. Kim, J. Mascola, M. Robb, 2003, AIDS research and human retroviruses.

Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans

Jerome H. Kim, M. Robb, G. Alter, 2018, Journal of Virology.

Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial

P. Pitisuttithum, J. Excler, A. Jongkaewwattana, 2023, Vaccine.

Psychosocial burden of women with abnormal Pap smears.

P. Pitisuttithum, B. Phonrat, S. Naksrisook, 2009, The Southeast Asian journal of tropical medicine and public health.

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age

N. Muñoz, X. Castellsagué, D. Ferris, 2011, British Journal of Cancer.

The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3